SEQUENTA, INC.

Profile

Company Names

SEQUENTA, INC.
MLC DX INC

Addresses

400 EAST JAIME COURT, SUITE 301, SOUTH SAN FRANCISCO, CA 94080

400 E JAMIE COURT, SUITE 301, SOUTH SAN FRANCISCO, CA 94080

409 ILLINOIS STREET, SAN FRANCISCO, CA 94158

3000 SAND HILL ROAD, BUILDING 3, SUITE 290, MENLO PARK, CA 94025

Phone Numbers

(650) 243-3900
(415) 978-2167
(415) 606-2276

 

Entity Type:

CORPORATION

Industry:

OTHER

Year Incorporated:

2008

State Incorporated:

DELAWARE

Total Amount Raised:

$38,958,387.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2013-06-20 
$20,000,001.00 
$20,000,001.00 
$0.00 
Equity 
3
2012-02-10 
$8,460,083.00 
$8,697,565.00 
$237,482.00 
Equity 
2
2010-08-02 
$8,498,303.00 
$9,737,414.00 
$1,239,111.00 
Equity 
1
2009-07-15 
$2,000,000.00 
$2,300,008.00 
$300,008.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROWAN 
 
CHAPMAN 
DIRECTOR
ATTLEE, INC.   |  MLC DX INC   |  SEQUENTA, INC.   |  VITAPATH GENETICS, INC.   |  EVIDATION HEALTH, INC.   |  VITRUVIAN NETWORKS INC.   |  VINETI, INC.   |  INITIATE STUDIOS, LLC   |  CELLANOME, INC.   |  BAKAR ENTREPRENEURSHIP FUND I, L.P.
BILL 
 
ERICSON 
DIRECTOR
NLIGHT PHOTONICS CORP   |  MLC DX INC   |  ARTEMIS HEALTH INC   |  ROCKET FUEL INC.   |  SEQUENTA, INC.   |  VISIBLE MEASURES CORP   |  VERINATA HEALTH INC   |  NLIGHT, INC.
MALEK 
 
FAHAM 
EXECUTIVE OFFICER, DIRECTOR
MLC DX INC   |  SEQUENTA, INC.   |  SERIMMUNE INC.   |  PROTILLION BIOSCIENCES, LNC.
EPHRAIM 
 
GILDOR 
DIRECTOR
SEQUENTA, INC.
JACOB 
 
GOLDFIELD 
DIRECTOR
MLC DX INC   |  SEQUENTA, INC.   |  CANDID CARE CO.
KAREN 
 
KIRK 
EXECUTIVE OFFICER
SEQUENTA, INC.
JOHN 
 
STUELPNAGEL 
DIRECTOR
TANDEM TECHNOLOGIES, INC.   |  SEQUENTA, INC.   |  ADAPTIVE BIOTECHNOLOGIES CORP   |  MUSE BIOTECHNOLOGY, INC.
JIM 
 
TANANBAUM 
DIRECTOR
SEQUENTA, INC.   |  MINDSTRONG, INC.   |  LIFEMINE THERAPEUTICS, INC.   |  KINNATE BIOPHARMA INC.   |  SERANOVA BIO, LLC   |  LATIGO BIOTHERAPEUTICS, INC.
THOMAS 
 
WILLIS 
EXECUTIVE OFFICER, DIRECTOR
MLC DX INC   |  SEQUENTA, INC.   |  BOREAL GENOMICS INC.   |  OSPREYDATA INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2013-07-02
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-20 
2012-02-23
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2012-02-10 
2010-11-19
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2010-08-02 
2010-08-11
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2010-08-02 
2009-07-29
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2009-07-15 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#